

An investor is not just buying real estate - they are buying a 100-year-old brand and a technology that is experiencing a renaissance today through quantum medicine and biohacking.
Whoever acquires Institut Zeileis is not only buying a property and a brand — they are buying a state approval that is unique in the world and impossible to replicate from a regulatory standpoint. That is the deepest moat a healthcare company can have.














